HBsAg seroclearance and reduction in late recurrence of HBV-related HCC: Causality or co-existence?

被引:2
|
作者
Diao, Yong-Kang [1 ,2 ]
Kong, Qing-Yu [3 ]
Yang, Tian [1 ,2 ]
机构
[1] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Dept Gen Surg,Canc Ctr,Div Hepatobiliary & Pancre, Hangzhou, Zhejiang, Peoples R China
[2] Second Mil Med Univ, Navy Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepatobiliary Surg, Shanghai, Peoples R China
[3] Nantong Univ, Dept Hepatobiliary Surg, Affiliated Hosp, Nantong, Jiangsu, Peoples R China
关键词
THERAPY;
D O I
10.1016/j.jhep.2022.06.009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1468 / 1469
页数:2
相关论文
共 20 条
  • [1] HBsAg seroclearance reduces the risk of late recurrence in HBV-related HCC
    Jin, Bao
    Du, Shunda
    Yang, Huayu
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 (05) : 1469 - 1470
  • [2] Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis
    Mao, Xianhua
    Cheung, Ka Shing
    Peng, Chengzhi
    Mak, Lung-Yi
    Cheng, Ho Ming
    Fung, James
    Peleg, Noam
    Leung, Howard H-W
    Kumar, Rajneesh
    Lee, Jeong-Hoon
    Shlomai, Amir
    Yuen, Man-Fung
    Seto, Wai-Kay
    [J]. HEPATOLOGY, 2023, 77 (05) : 1735 - 1745
  • [3] Association of HBV/inflammation and sternness expression in HBV-related HCC recurrence
    Chang, Te-Sheng
    Lee, Kam-Fai
    Lin, Hsin-Yi
    Tung, Shui-Yi
    Kuo, Liang-Mou
    Jen, Xin-Wei
    Huang, Yen-Hua
    [J]. CANCER RESEARCH, 2011, 71
  • [4] HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma
    Sohn, Won
    Paik, Yong-Han
    Kim, Jong Man
    Kwon, Choon Hyuk
    Joh, Jae Won
    Cho, Ju Yeon
    Gwak, Geum-Youn
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (07) : 2429 - 2435
  • [5] HBV DNA and HBsAg Levels as Risk Predictors of Early and Late Recurrence after Curative Resection of HBV-related Hepatocellular Carcinoma
    Won Sohn
    Yong-Han Paik
    Jong Man Kim
    Choon Hyuk Kwon
    Jae Won Joh
    Ju Yeon Cho
    Geum-Youn Gwak
    Moon Seok Choi
    Joon Hyeok Lee
    Kwang Cheol Koh
    Seung Woon Paik
    Byung Chul Yoo
    [J]. Annals of Surgical Oncology, 2014, 21 : 2429 - 2435
  • [6] Similar recurrence after curative treatment of HBV-related HCC regardless of HBV replication activity
    Kim, Mi Na
    Kim, Beom Kyung
    Cho, Heejin
    Goh, Myungji
    Yu, Su Jong
    Sinn, Dong Hyun
    Park, Soo Young
    Kim, Seung Up
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S513 - S514
  • [7] Similar recurrence after curative treatment of HBV-related HCC, regardless of HBV replication activity
    Kim, Mi Na
    Kim, Beom Kyung
    Cho, Heejin
    Goh, Myung Ji
    Roh, Yun Ho
    Yu, Su Jong
    Sinn, Dong Hyun
    Park, Soo Young
    Kim, Seung Up
    [J]. PLOS ONE, 2024, 19 (08):
  • [8] Antiviral therapy, HBsAg seroclearance and late recurrence of hepatitis B-related hepatocellular carcinoma
    Liu, Si-Yu
    Yuan, Chen
    Tong, Xiang-Min
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 (05) : 1471 - 1472
  • [9] HBsAg-BASED MODELS TO PREDICT EARLY AND LATE RECURRENCE AFTER CURATIVE RESECTION IN PATIENTS WITH HBV-RELATED HEPATOCELLULAR CARCINOMA
    Lee, I-Cheng
    Chau, Gar-Yang
    Su, Chien-Wei
    Huo, Teh-Ia
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    [J]. HEPATOLOGY, 2019, 70 : 230A - 230A
  • [10] Predictors of long-term recurrence and survival after resection of HBV-related hepatocellular carcinoma: the role of HBsAg
    Lee, I-Cheng
    Lei, Hao-Jan
    Chau, Gar-Yang
    Yeh, Yi-Chen
    Wu, Chi-Jung
    Su, Chien-Wei
    Huo, Teh-la
    Chao, Yee
    Lin, Han-Chieh
    Hou, Ming-Chih
    Huang, Yi-Hsiang
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (07): : 3711 - 3725